McKesson Europe AG
XHAM:CLS1
Gross Margin
McKesson Europe AG
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR |
10%
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
87.4B USD |
4%
|
|
| US |
|
Cencora Inc
NYSE:COR
|
54.2B USD |
3%
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
54.1B USD |
3%
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
33.6B USD |
3%
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
33.1B AUD |
9%
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
68B CNY |
32%
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD |
32%
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
30%
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD |
13%
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
53.9B CNY |
11%
|
McKesson Europe AG
Glance View
McKesson Europe AG traces its roots back over a century, intertwining its growth story with the evolving landscape of healthcare in Europe. As a pivotal player in the distribution and retail of pharmaceuticals, McKesson Europe bridges the critical gap between manufacturers and patients. They operate a vast network of pharmacies spread across numerous countries, alongside an extensive distribution system. This infrastructure ensures medicines and health products swiftly reach their destinations, whether it be sprawling urban areas or remote rural locales. Through this network, McKesson Europe not only guarantees the delivery of essential drugs but also emphasizes efficiency and reliability, crafting a reputation that enhances its commercial success. Revenue streams for McKesson Europe derive from its multifaceted approach to healthcare services. The company thrives on both the wholesaling aspect, where it supplies drugs and health products to independent pharmacies and hospitals, and its retail operations through pharmacy chains. Moreover, McKesson Europe extends its business model by providing management services to independent pharmacies, optimizing their operations and supply chains. With the ever-growing demand for healthcare solutions in Europe, the company capitalizes on this pressing need, utilizing its vast logistical capabilities and deep industry knowledge to maintain its position as a leader in the pharmaceutical distribution and retail sectors. This strategic combination of services enables McKesson Europe AG to sustain its business momentum, adapting to the changing needs of the healthcare market.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on McKesson Europe AG's most recent financial statements, the company has Gross Margin of 10.3%.
You don't have any saved screeners yet